Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR

Molecular Therapy

Volumn 8, Issue 6, 2003, Pages 1009-1016

  Ishii Watabe, Akiko ^a   Uchida, Eriko ^b   Iwata, Akiko ^b,c   Nagata, Ryuji ^b   Satoh, Kouei ^c   Fan, Kejun ^d   Murata, Mitsuhiro ^d   Mizuguchi, Hiroyuki ^b   Kawasaki, Nana ^a   Kawanishi, Toru ^a   Yamaguchi, Teruhide ^b   Hayakawa, Takao ^e  

^a Div of Biological Chemistry/Biol   (Japan)

^b Div of Cell and Gene Ther Prod   (Japan)

^c Institute of Saitama Red Cross   (Japan)

^d JSR CORPORATION   (Japan)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Infectivity PCR; Replication competent adenovirus

Indexed keywords

ADENOVIRUS VECTOR; GLASS; PRIMER DNA; VIRUS DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA EXTRACTION; DNA PROBE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0346025620     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.09.001     Document Type: Article

References (29)

1. http://www.wiley.co.uk/wileychi/genmed/clinical/.
2. Mizuguchi, H., et al. (2001). A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8: 730-735.
3. Mizuguchi, H., et al. (2002). CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptice, do not change the systemic gene transfer properties in mice. Gene Ther. 9: 769-776.
4. Belousova, N., Krendelchtchikova, V., Curiel, D. T., and Krasnykh, V. (2002). Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J. Virol. 76: 8621-8631.
5. Koizumi, N., et al. (2001). Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim. Biophys. Acta 1568: 13-20.
6. Mizuguchi, H., and Hayakawa, T. (2002). Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther. 9: 236-242.
7. Mizuguchi, H., and Hayakawa, T. (2002). Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 285: 69-77.
8. Mizuguchi, H., and Hayakawa, T. (2001). Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim. Biophys. Acta 1568: 21-29.
9. Mizuguchi, H., and Hayakawa, T. (2002). The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector. J. Gene Med. 4: 240-247.
10. Sakhuja, K., et al. (2003). Optimization of the generation and propagation of gutless adenoviral vectors. Hum. Gene Ther. 14: 243-254.
11. Lochmuller, H., et al. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (Δ E1 + Δ E3) during multiple passages in 293 cells. Hum. Gene Ther. 5: 1485-1491.
12. Guidance for human somatic cell therapy and gene therapy (2001). Hum. Gene Ther. 12: 303-314.
13. Roitsch, C., et al. (2001). Characterization and quality control of recombinant adenovirus vectors for gene therapy. J. Chromatogr. B Biomed. Sci. Appl. 752: 263-280.
14. Zhu, J., et al. (1999). Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10: 113-121.
15. Zhang, W. W., Koch, P. E., and Roth, J. A. (1995). Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18: 444-447.
16. Simmonds, P., et al. (1990). Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64: 864-872.
17. Yei, S., Yu, M. W., and Tankersley, D. L. (1992). Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma. Transfusion 32: 824-828.
18. Louis, N., Evelegh, C., and Graham, F. L. (1997). Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233: 423-429.
19. Aritomi, T., et al. (1998). Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis. Jpn. J. Gastroenterol. Hepatol. 11: 1125-1132.
20. Harvey, B. G., et al. (1999). Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 73: 6729-6742.
21. Hutchins, B. (2002). Development of a reference material for characterizing adenovirus vectors. BioProcessing J. 1: 25-28.
22. Dion, L. D., Fang, J., and Garver, R. I. Jr. (1996). Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J. Virol. Methods 56: 99-107.
23. Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors (2001). Hum. Gene Ther. 12: 315-320.
24. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee (2002). Hum. Gene Ther. 13: 3-13.
25. Gao, G. P., Engdahl, R. K., and Wilson, J. M. (2000). A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. Hum. Gene Ther. 11: 213-219.
26. Fallaux, F. J., et al. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9: 1909-1917.
27. Schiedner, G., Hertel, S., and Kochanek, S. (2000). Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 11: 2105-2116.
28. Nyberg-Hoffman, C., Shabram, P., Li, W., Giroux, D., and Aguilar-Cordova, E. (1997). Sensitivity and reproducibility in adenoviral infectious titer determination. Nat. Med. 3: 808-811.
29. Mizuguchi, H., and Kay, M. A. (1998). Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9: 2577-2583.